Loading...
Beta Bionics, Inc.
BBNX•NASDAQ
Healthcare
Medical - Equipment & Services
$19.11
$-0.38(-1.95%)
Beta Bionics, Inc. (BBNX) Financial Performance & Statements
Review Beta Bionics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
442.93%
↑ 442.93%
Operating Income Growth
-26.22%
↓ 26.22%
Net Income Growth
-24.17%
↓ 24.17%
Operating Cash Flow Growth
-48.78%
↓ 48.78%
Operating Margin
-76.95%
↓ 76.95%
Gross Margin
54.31%
↑ 54.31%
Net Profit Margin
-101.82%
↓ 101.82%
ROE
-57.31%
↓ 57.31%
ROIC
-16.21%
↓ 16.21%
Beta Bionics, Inc. (BBNX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Beta Bionics, Inc. stock.
| Metric | Q4 2024 | Q3 2024 |
|---|---|---|
| Revenue | $20.44M | $16.70M |
| Cost of Revenue | $8.75M | $7.79M |
| Gross Profit | $11.69M | $8.91M |
| Gross Profit Ratio | $0.57 | $0.53 |
| R&D Expenses | $9.21M | $5.14M |
| SG&A Expenses | $15.51M | $14.75M |
| Operating Expenses | $24.73M | $19.89M |
| Total Costs & Expenses | $33.48M | $27.68M |
| Interest Income | $951000.00 | $0.00 |
| Interest Expense | -$2000.00 | $0.00 |
| Depreciation & Amortization | $529000.00 | $306333.00 |
| EBITDA | -$12.80M | -$10.67M |
| EBITDA Ratio | -$0.63 | -$0.64 |
| Operating Income | -$13.04M | -$10.98M |
| Operating Income Ratio | -$0.64 | -$0.66 |
| Other Income/Expenses (Net) | -$5.07M | $1.24M |
| Income Before Tax | -$18.11M | -$9.74M |
| Income Before Tax Ratio | -$0.89 | -$0.58 |
| Income Tax Expense | $0.00 | $0.00 |
| Net Income | -$18.11M | -$9.74M |
| Net Income Ratio | -$0.89 | -$0.58 |
| EPS | -$0.42 | -$1.55 |
| Diluted EPS | -$0.42 | -$1.55 |
| Weighted Avg Shares Outstanding | $43.35M | $6.26M |
| Weighted Avg Shares Outstanding (Diluted) | $43.35M | $6.26M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan